The global prescription dermatological drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Prescription dermatological drugs are aimed to treat various diseases related to skin, such as pigmentation, acne, wrinkles, and psoriasis as well as diseases related to nails, and hair. These drugs are used to treat skin conditions and also to prevent certain skin disorders. Multiple skin conditions such as acne, atopic dermatitis, and psoriasis, among other conditions, are treated through dermatological drugs. A large number of drugs have been approved by the FDA and other regulatory bodies of different nations for several skin conditions and disorders. This is anticipated to be the major factor contributing substantially to the global prescription dermatological drugs market.

The other factors that are expected to boost the market include a rise in demand for topical dermatological drugs such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients to treat acne. Furthermore, the rise in awareness about skin diseases, growing visits to dermatologists all over the globe, and surge in the incidence of skin cancer and other skin disorders are some factors that are anticipated to accelerate the growth of the market. Furthermore, a rise in awareness related to the use of topical ointments for the management and treatment of psoriasis is another major factor that fuels the growth of the global prescription dermatological drugs market during the forecast period. However, stringent government regulations restrain the growth of the global prescription dermatology drugs market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By Distribution Channel

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Galderma S.A., Johnson & Johnson Services, Inc., and Bayer AG, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Prescription Dermatological Drugs Market Report by Segment

By Type

• Anti-Acne Drugs
• Psoriasis Drugs
• Anti-Aging Drugs
• Dermatitis Drugs
• Skin Cancer Drugs
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Prescription Dermatological Drugs Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa